Links to articles in the current and previous 2 issues of this bulletin are displayed below.
To receive email notifications about new issues of this bulletin, please email richard.fallis@healthcarelibrary.qub.ac.uk to subscribe.
Endothelial dysfunction in patients with type 2 diabetes: the truth is in the blood
Glucose management indicator: do we need device-specific equations?
Impact of SGLT-2i on COPD exacerbations in patients with type 2 diabetes mellitus
Predictors of mortality in patients with multiple endocrine neoplasia type 1
Setting for initial education about type 1 diabetes
Shared decisionmaking in the treatment of hypothyroidism
Archives of Gerontology and Geriatrics (Aug); Clinical Endocrinology (Jul); Diabetes & Metabolism (Jul); Journal of Clinical Investigation, The (May); Lancet Diabetes and Endocrinology, The (Jun); NEJM (Jun)
Adrenocortical carcinoma: a practical guide for clinicians
Age and sex differences in efficacy of treatments for type 2 diabetes: a network meta-analysis
Challenges in care provision for children and adolescents with differences of sex development
The cost of adrenal insufficiency in England—analysis of NHS HES data
Definition and diagnostic criteria of clinical obesity
Diabetes can impact cellular immunity in solid tumors
Ghrelin: an emerging therapy for heart failure
Klinefelter syndrome: a review
The metabolic programming of pubertal onset
A randomized trial of automated insulin delivery in type 2 diabetes
The role of the hypothalamic–pituitary–thyroid axis in thyroid cancer
Clinical Endocrinology (Apr-Jun); JAMA (Mar); JAMA Internal Medicine (Apr); Lancet, The (Mar); Lancet Diabetes and Endocrinology, The (Mar-May); NEJM (May); Trends in Immunology (Apr)
Biomarkers and diagnostic thresholds for congenital hyperinsulinism
Dissection of type 2 diabetes: a genetic perspective
Effects of GLP-1 receptor agonists on kidney and cardiovascular disease outcomes
Elacestrant for treating oestrogen receptor-positive HER2-negative advanced breast cancer with an ESR1 mutation after endocrine treatment (new NICE guideline TA1036)
Finerenone and new-onset diabetes in heart failure: a prespecified analysis of the FINEARTS-HF trial
Glucagon‐like peptide 1 (GLP‐1) receptor agonists for people with chronic kidney disease and diabetes (new Cochrane intervention review)
Hypothalamic obesity: from basic mechanisms to clinical perspectives
Is it time to revisit the recommendations for initiation of menopausal hormone therapy?
Managing hypoglycaemia in patients with insulinoma
Outcomes after medical treatment for primary aldosteronism
PEG precipitation to detect macro-TSH in clinical practice: a systematic review
Selpercatinib for advanced thyroid cancer with RET alterations after treatment with a targeted cancer drug in people 12 years and over (new NICE guideline TA1038)
Setmelanotide in patients aged 2–5 years with rare MC4R pathway-associated obesity (VENTURE)
The use of prednisolone 2.5 mg daily during Ramadan fasting in patients with adrenal insufficiency
Clinical Endocrinology (Feb-Mar); Cochrane Library (Jan-Feb); Lancet Diabetes and Endocrinology, The (Jan-Feb); NICE website (Jan-Feb)
The Healthcare Library cannot guarantee the correctness or completeness of the information in these bulletins. The information is subject to change and we cannot guarantee it will remain up-to-date. It is your responsibility to check the accuracy and validity of the information. These bulletins are the property of the Healthcare Library; please credit us if re-using or distributing content from them.